Endo Pharmaceuticals Inc.

Industry:	Pharmaceuticals, Drug Manufacturing & Research
Revenues:	$20 Million
Employees:	130

Description

Endo Pharmaceuticals Holdings Inc., incorporated on November 18, 1997, is a specialty pharmaceutical company in pain management. The Company is engaged in the research, development, sales and marketing of branded and generic pharmaceutical products primarily to treat and manage pain. Its portfolio of branded products includes Lidoderm, Opana ER, Percocet, and Frova. The Company concentrates on generics that have one or more barriers to market entry, such as complex formulation, regulatory or legal challenges or difficulty in raw material sourcing. Its branded products pipeline includes three products in Phase III clinical trials, three products in Phase II clinical trials and one product in Phase I trials. During the year ended December 31, 2007, the branded products and non-branded generic portfolio comprised approximately 92% and 8%, respectively, of the Company's net sales.
(Source: 10-K)

Products & Services

prescription pharmaceuticals, pain management, product offering

Find More Jobs

Job Openings

Vice President, Implant Technologies R&D

District Manager

Vice President Implant Technology Chadds Ford , PA

Pharmaceutical District Sales Manager Boston , MA

Vice President, Specialty Generics Sales & Marketing

View More Statistics

Site Statistics

Monthly Unique Visitors:	13,987
Site Rank:	122,165
Trust Rating:	Neutral
Stats by

News Archive

Endo Pharmaceuticals Announces Expiration of Cash Tender Offer for Ledgemont PhaRMA(SM) Secured 16% Notes. PR Newswire; 9/25/2009 ...PRNewswire-FirstCall/ -- Endo Pharmaceuticals announced today the expiration...wholly-owned subsidiary, Endo Pharmaceuticals Solutions Inc., for any...Ledgemont Royalty Sub LLC, Endo Pharmaceuticals Solutions Inc.'s wholly... ...more

Endo Pharmaceuticals Announces Cash Tender Offer for Any and All Outstanding Ledgemont PhaRMA(SM) Secured 16% Notes. PR Newswire; 8/26/2009 ...PRNewswire-FirstCall/ -- Endo Pharmaceuticals announced today the commencement...wholly-owned subsidiary, Endo Pharmaceuticals Solutions Inc., for any...Ledgemont Royalty Sub LLC, Endo Pharmaceuticals Solutions Inc.'s wholly... ...more

Endo Pharmaceuticals Announces Expiration of Cash Tender Offer for Ledgemont PhaRMASM Secured 16% Notes. Biotech Week; 10/7/2009 Endo Pharmaceuticals (NASDAQ:ENDP) announced the...its wholly-owned subsidiary, Endo Pharmaceuticals Solutions Inc., for any and all...of Ledgemont Royalty Sub LLC, Endo Pharmaceuticals Solutions Inc.'s wholly-owned... ...more